Home » UK Backs Novartis Multiple Sclerosis Pill
UK Backs Novartis Multiple Sclerosis Pill
Novartis’s multiple sclerosis pill Gilenya has been recommended for use on the UK’s publicly funded National Health Service, a welcome decision for the Swiss drugmaker regarding a potential blockbuster product whose safety profile has come into question.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
07May
-
14May
-
30May